Femasys Inc (FEMY)
Healthcare
Medical Instruments & Supplies
2.90 $
-1.7%
vs. previous close
Closing price · As of: 31. Jul 2026
Femasys Inc (FEMY) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -19 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| -11 | -4.9 | -7.9 | -11 | -11 | -19 | -19 | |
| 1.1 | 1.1 | 1.0 | 0.9 | 0.9 | 0.9 | 0.8 | |
| 0.4 | 0.3 | 0.2 | 0.2 | 0.7 | 0.4 | 0.8 | |
| 0.3 | 0.3 | -0.6 | 0.2 | – | – | – | |
| -1.1 | 0.6 | -0.7 | -0.5 | 1.2 | -3.1 | -2.1 | |
| 0.7 | 0.0 | 0.3 | 0.4 | 0.1 | 0.8 | 0.5 | |
| 12 | 1.0 | -0.3 | -0.4 | -0.1 | -0.8 | -0.6 | |
| 0.0 | 0.2 | – | – | – | – | – | |
| -0.1 | 0.8 | -0.5 | -0.5 | 6.2 | 0.0 | 4.1 | |
| -0.1 | 0.9 | 30 | -0.7 | 20 | 2.0 | 25 | |
| 1.2 | -3.1 | 21 | -12 | 8.8 | -18 | 5.8 | |
| -12 | -5.0 | -8.2 | -11 | -11 | -20 | -19 |
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.